Clinical trial
Long-Term Open-Label Study to Assess the Safety and Efficacy of Vatiquinone in Patients With Friedreich Ataxia
NCT05515536 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Open-Label Study to Assess the Safety and Efficacy of Vatiquinone in Patients With Friedreich Ataxia
- Lead sponsor
- PTC Therapeutics
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- December 8, 2022
- Completion date
- December 31, 2027
- Enrollment
- 130 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.